Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. - Wikidata - wikimedia - TriplyDB

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

http://www.wikidata.org/entity/Q33683729

about

Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung Overview of the biology of type I interferons The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity The role for protein tyrosine phosphatase non-receptor type 22 in regulating intestinal homeostasis Immunomodulatory functions of type I interferons Ontogeny of intestinal epithelial innate immune responses Multiple roles of toll-like receptor 4 in colorectal cancer Indoleamine 2,3 dioxygenase in intestinal disease Human β-Defensin 3 [corrected] Exacerbates MDA5 but Suppresses TLR3 Responses to the Viral Molecular Pattern Mimic Polyinosinic:Polycytidylic Acid Activation of anti-hepatitis C virus responses via Toll-like receptor 7.Osteopontin expression by CD103- dendritic cells drives intestinal inflammation Twist mediates suppression of inflammation by type I IFNs and Axl TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice Generation of mouse small intestinal epithelial cell lines that allow the analysis of specific innate immune functions The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury.Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice.Isolation of bacteria from mouse caecal samples and description of Bacteroides sartorii sp. nov.The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms.Fetal exposure to maternal inflammation does not affect postnatal development of genetically-driven ileitis and colitis TLR8-mediated activation of human monocytes inhibits TL1A expression.Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans.STAT2 contributes to promotion of colorectal and skin carcinogenesis.Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitis Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense.NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitis High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis.Microbes in gastrointestinal health and disease Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis.MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18 Regulation of cysteinyl leukotriene receptor 2 expression--a potential anti-tumor mechanism.Toll-like receptors in inflammatory bowel diseases: a decade later.Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity.Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits Toll-like receptor 9 gene mutations and polymorphisms in Japanese ulcerative colitis patients.

P2860

Q21131368-7710F4EB-D4BF-4522-AFD5-F3A14D5537A5 Q21195364-93759CD4-E408-4FF6-A4D9-672E6BB9CA8F Q24310219-525548B3-2BB0-4B44-BBAF-C41209C2BEA6 Q26741130-FB21ED71-58EE-4BDF-80D2-C4E0D0ED0F5D Q26823904-8A236D63-D0C5-423C-9656-527FDC060E1E Q27004090-A9D56701-E31B-4C96-A74F-38F76E154839 Q27008380-DE7E0294-BC04-4942-95A0-B310974AC6B9 Q27025063-1BBCC841-310D-48DD-94AE-3D4C047A1179 Q27310039-6EFFBE96-D1E3-41E7-91B0-DDF34B28EBD3 Q27473105-821590BA-1489-4B3F-8DD7-BCDC2BCDA3FB Q28307824-39B41025-B2C0-40B2-8FDF-18CA0CF3DFAD Q28509359-E9A06B84-58D0-4BD1-90AE-5D559C745E3E Q28513789-FA5B7BED-1CA3-475C-9F8F-E38CBA7C4CE6 Q28535135-D3AFBB3A-817B-4403-BC80-1C2317B6E4DA Q30577895-41490A7E-E9C5-495B-A2E0-4DF3B7B896EB Q33381642-0E1F0E1D-5868-49F2-B172-C736274A57CF Q33406281-064230AD-C320-4AB7-BC71-E4A8EBC27C34 Q33412853-6D40DDB6-9FB2-4868-9C22-A3A8E3E654DC Q33549739-1357040E-5256-4492-A833-B64810CDF2B2 Q33594436-51CA1E36-9445-4168-BB46-D37C7715ED53 Q33607300-118E37AF-56A2-4E5E-88C5-03988FA491CF Q33645831-64A6BA88-C62A-4BEA-B880-4084B38863AC Q33731098-F219C1BB-4BAF-41CC-9B29-B9513705E233 Q33746984-83497995-32D8-44FE-A89D-D190D6268067 Q33776485-49C56BFA-99E4-4A69-B408-2AD0A4036AEC Q33788157-8C6ABB50-6F03-44EC-8CA7-33BD0CE4AE2D Q33802845-0E1808A5-9439-4740-A70E-F2FE7C61D2E0 Q33814705-6DC37BE4-1B06-4985-8053-E40D4F51785B Q33815718-67EF1C38-2215-4CC4-B10A-445D07737074 Q33834191-6BE8EF9A-A8D4-4DAC-BA24-B7C69DA5B694 Q33898849-0520C468-218C-4E31-8885-FD001545ED95 Q33943525-0F90A6B8-23C4-444B-BA20-4C6F1F777C44 Q33962421-59B96306-25E9-4351-A4A9-B3E848279D2B Q34044424-A04AD67C-4D53-4471-B3FF-265E1C209676 Q34110714-067B5747-ABD9-4FFA-83B0-77BE42C2FAC2 Q34134813-AD10F511-5AE3-41F9-BFB0-F5B5C6DE0E87 Q34154099-F53B0F2A-A9A6-45CB-B4EA-92006435200C Q34164176-3BB26794-DE1D-4629-A17E-149B1640F51A Q34314273-F636D603-D818-473C-A697-7E69CE6385C1 Q34406452-06FBC5D5-9B8E-4F97-BE87-0DB9E31E94D2

P2860

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

http://www.wikidata.org/entity/Q33683729

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

@ast

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

@en

type

label

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

@ast

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

@en

prefLabel

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

@ast

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

@en

P1433

Q33683729-4115B42D-114F-44C0-9319-EB08F04E9F6D

P1476

Q33683729-F94C6AB0-7DD8-4ABE-AF4C-C74D949E43E7

P2093

Q33683729-0AD03843-157C-4847-B192-90127C67C26B

Q33683729-1D32BD0F-2CB0-4579-81B2-4F557716BB10

Q33683729-6388403B-9778-44E6-A21A-44FB94979E31

Q33683729-6914CDED-9DEC-417B-B495-28D76B4833E6

Q33683729-7715645B-0D80-4CCD-A7D8-142DE2557BB2

Q33683729-A081C2E0-8C4A-4480-BF8D-C3ED1C8C627E

P2860

Q33683729-040AF731-B680-4568-9147-A815A5FE1290

Q33683729-07E67E23-F16E-460D-A7B4-E9AD233C54B6

Q33683729-0A88554F-4FEC-46C7-B7F9-95EF5B3A6AFD

Q33683729-0BA739FF-5E25-457C-A810-B28F13478C42

Q33683729-1243D316-3864-4D5A-B2AC-B3337A3CCE01

Q33683729-1A63AC3F-77A1-4FF2-A9CE-11B60CDD2810

Q33683729-26E8D672-DA82-488D-A786-06CFF46120E5

Q33683729-291DAE00-14F0-4788-8130-8551F6370727

Q33683729-2AE46BEA-B5BB-443C-8499-DEB11D5254AD

Q33683729-32D210FA-A09B-4026-BEE2-92B5936887CE

P304

Q33683729-993F2F22-5445-4CE4-9775-FFC33437771D

P31

Q33683729-391D54AA-3F7C-43E7-8FF4-68BE8C394B7B

P356

Q33683729-508C5FBE-C178-4A8B-8DA0-62088A557F10

P407

Q33683729-DBA0E277-ABE9-4D50-9671-2D5C45BF7B9E

P433

Q33683729-4EDCA881-AC30-4C2B-97F1-13CA026EF972

P478

Q33683729-2D98EA24-AD1B-46C0-BBDB-83CEC62BF6AF

P577

Q33683729-61373AAD-6171-4C22-A6B8-8A33CE8BEDF9

P5875

Q33683729-E14BA97C-9831-41C0-9962-052F26828399

P698

Q33683729-D8250880-5532-4F8A-9B8A-0292432BADCE

P921

Q33683729-83A2A093-A1C2-4E23-A260-6EFA3949EA48

P932

Q33683729-F74E34AE-A1D9-436E-ABA4-D8715241C245

P356

P1433

Journal of Clinical Investigation

P1476

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

@en

P2093

Daniel Rachmilewitz

http://www.w3.org/2001/XMLSchema#string

Eyal Raz

http://www.w3.org/2001/XMLSchema#string

Gloria Li

http://www.w3.org/2001/XMLSchema#string

Jongdae Lee

http://www.w3.org/2001/XMLSchema#string

Kyoko Katakura

http://www.w3.org/2001/XMLSchema#string

Lars Eckmann

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory Bowel Disease

A Toll-like receptor recognizes bacterial DNA

Toll-like receptors

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

IRF family of transcription factors as regulators of host defense

Identification of Lps2 as a key transducer of MyD88-independent TIR signalling

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

Role of cytokines in the pathogenesis of inflammatory bowel disease.

Interferon regulatory factor-3 is an in vivo target of DNA-PK.

The immunological and genetic basis of inflammatory bowel disease.

P304

695-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI22996

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7969714

http://www.w3.org/2001/XMLSchema#string

P698

15765149

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

1051992

http://www.w3.org/2001/XMLSchema#string